BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 4047274)

  • 1. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
    Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C
    Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological Spectrum and Short-Term Outcome of Treatment with Cyclophosphamide in Relapsing Steroid-Sensitive Nephrotic Syndrome.
    Bajeer IA; Khatri S; Tresa V; Hashmi S; Mubarak M; Lanewala AA
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):436-439. PubMed ID: 29848418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late resistance to corticosteroids in nephrotic syndrome.
    Srivastava RN; Agarwal RK; Moudgil A; Bhuyan UN
    J Pediatr; 1986 Jan; 108(1):66-70. PubMed ID: 3944696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.
    Schulman SL; Kaiser BA; Polinsky MS; Srinivasan R; Baluarte HJ
    J Pediatr; 1988 Dec; 113(6):996-1001. PubMed ID: 3193322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
    Inaba A; Hamasaki Y; Ishikura K; Hamada R; Sakai T; Hataya H; Komaki F; Kaneko T; Mori M; Honda M
    Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
    J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do current recommendations for kidney biopsy in nephrotic syndrome need modifications?
    Gulati S; Sharma AP; Sharma RK; Gupta A; Gupta RK
    Pediatr Nephrol; 2002 Jun; 17(6):404-8. PubMed ID: 12107803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Response and Long-Term Renal Outcomes in Childhood Idiopathic Steroid-Resistant Nephrotic Syndrome: A Single-Center Study.
    Jung J; Lee JH; Park YS
    Nephron; 2022; 146(4):327-334. PubMed ID: 34929692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment.
    Siegel NJ; Gaudio KM; Krassner LS; McDonald BM; Anderson FP; Kashgarian M
    Kidney Int; 1981 Mar; 19(3):454-9. PubMed ID: 7241883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of repeat renal biopsies in children with nephrotic syndrome.
    Ahmad H; Tejani A
    Nephron; 2000 Apr; 84(4):342-6. PubMed ID: 10754411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure.
    Moura LR; Franco MF; Kirsztajn GM
    J Bras Nefrol; 2015; 37(4):475-80. PubMed ID: 26648497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paucity of minimal-change lesion in children with early frequently relapsing steroid-responsive nephrotic syndrome.
    Trachtman H; Carroll F; Phadke K; Khawar M; Nicastri A; Chen CK; Tejani A
    Am J Nephrol; 1987; 7(1):13-7. PubMed ID: 3578368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of primary nephrotic syndrome in Egyptian children.
    Kaddah A; Sabry S; Emil E; El-Refaey M
    J Nephrol; 2012; 25(5):732-7. PubMed ID: 22101675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis.
    Ponticelli C; Rivolta E
    Am J Nephrol; 1990; 10 Suppl 1():105-9. PubMed ID: 2256469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.